FACULTY/PLANNING COMMITTEE MEMBERS

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, PA

Ellen H. Miller, MD
Professor of Science Education & Medicine
Hofstra Northwell School of Medicine
Senior Medical Director
North Shore – LIJ CareConnect
East Hills, NY

TARGET AUDIENCE

This activity is targeted to any primary care clinician who treats patients with type 2 diabetes.

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT

This activity is supported by independent educational grants from: Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc; and Novo Nordisk.

METHOD OF PARTICIPATION

To receive credit for this activity, the participant must read the CME information (including learning objectives and disclosures) and review the entire activity. Upon finishing the activity, participant must complete the session post-test, evaluation, and all required personal information. To receive CME certificate, participant will need to pass the post-test with 75% accuracy or better. If participant receives less than 75%, participant should review the activity and take the test again.

POST-TEST AND EVALUATION

After completing the CME activity, participant must check on the box attesting to their participation in the activity. After successful completion of the post-test, participant will be asked to fill out a program evaluation form and prompted to print and/or save the CME certificate. Participant should PLEASE be ready to print and/or save certificate at this time.

STATEMENT OF DISCLOSURE AND INDEPENDENCE

It is the policy of Primary Care Network (PCN) to ensure all of its accredited educational activities are planned, developed, and conducted in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Essential Areas and Policies. In accordance with ACCME requirements, PCN has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that PCN accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.

PCN’s Resolution of Personal COI Policy aims to ensure that all potential conflicts are identified and resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a PCN accredited Continuing Medical Education (CME) activity are considered Planning Committee Members. Planning Committee Members include individuals involved in a CME activity who may develop, edit, review and/or present content. Planning Committee Members are required to disclose to the participants any real or apparent conflict(s) of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.

The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentation are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Medical Education Exchange, Primary Care Network, advisory boards and consultants, or the activity’s commercial supporter(s).

FACULTY DISCLOSURE

M. Susan Burke, MD, FACP
Speaker’s Bureau: Merck & Co.

Ellen H. Miller, MD
No relevant financial relationships to disclose.

REVIEW COMMITTEE DISCLOSURE

In accordance with PCN policy, all content is reviewed by independent peer reviewers for balance, objectivity, and commercial bias. The peer reviewers have the following disclosures:

Brian Koffman, MDCM

Advisory Board & Speaker’s Bureau: AstraZeneca, Daiichi-Sankyo
Patient Speaker: AbbVie, Janssen Pharmaceuticals, Inc.

Jill Hays, CHCP
No relevant financial relationships to disclose

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

The opinions, ideas, recommendations, and perspectives expressed in this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards or consultants.

CONTACT INFORMATION

Visit www.primarycarenetwork.org or email us at education@primarycarenetwork.org

Hardware/Software Requirements
Policy on Privacy and Confidentiality
Copyright